ArticleThe Journal of reproduction and development2026
Spheroid granulosa cell supplementation improves granulosa cell-oocyte interactions and enhances in vitro growth of oocytes in cows.
Article in The Journal of reproduction and development, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Oocytes develop through bidirectional communication with surrounding granulosa cells (GCs), and differences in the GC environment represent a major distinction between in vivo and in vitro oocyte growth systems. However, the influence of GC number and organization on oocyte growth and quality during in vitro culture remains unclear. In this study, oocyte-granulosa cell complexes (OGCs) derived from early antral follicles (0.5-0.7 mm) of cows were supplemented with spheroid granulosa cells (GC-S) derived from antral follicles (3-5 mm). GC-S were incorporated into OGCs during 14 days of incubation. Oocyte characteristics, maturation, and fertilization competence were evaluated, and the transcriptomic profiles of surrounding GCs were analyzed by RNA sequencing. GC-S supplementation increased transzonal projections and improved GC survival within OGCs, indicating enhanced GC-oocyte interactions. It also increased ATP content, oocyte diameter, and DNA methylation levels, reaching levels comparable to those observed in in vivo-grown oocytes. Furthermore, GC-S supplementation significantly improved oocyte maturation and fertilization rates, although these remained lower than those of in vivo counterparts. In contrast, lipid content, mitochondrial DNA copy number, and mitochondrial membrane potential were not affected and remained lower than those of in vivo-grown oocytes. RNA-seq analysis revealed that GC-S supplementation altered the expression of genes associated with focal adhesion and cytoskeleton-related pathways toward those observed in vivo. These results demonstrate that spheroid GC supplementation improves GC-oocyte interactions and partially restores in vivo-like characteristics of oocytes during in vitro growth.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.